Torx Software and CDD Vault to Collaborate on Global Drug Discovery

On Sept. 12, 2023, Torx Software Limited announced a collaboration with CDD Vault to allow for the smooth synthesis and registration of new compounds throughout the small-molecule discovery process. Torx is a cloud-based platform created by Cresset and Elixir Software that provides a space for chemistry teams to collaborate, design molecules, and track compound synthesis throughout the design-make-test-analyze (DMTA) cycle. CDD Vault is a hosted data management system for chemical registration and safe storage of scientific data.

Data obtained in Torx can be easily transferred and stored in CDD Vault, which aims for ideal productivity and security. Any of the Torx modules can initiate CDD Vault integration, allowing chemists and managers easy access to data from the CDD vault. These data will hopefully assist throughout the DMTA process, making all steps in the cycle more effective. Gathering registration data in Torx allows chemists to review and approve molecule syntheses prior to automatic deposition in CDD vault via the API integration. As a result, they will be able to work more effectively in a single application while gathering detailed DMTA metrics and data.

In a press release for Torx, Dr Barry Bunin, CEO of CDD Vault, said, "CDD Vault is a whole solution for drug discovery informatics structure activity relationship (SAR) management differentiated via ease-of-adoption and scalable data partitioning capabilities. We believe in the value of collaboration and building an ecosystem of software partners that together can better serve our customers. CDD Vault's integration with Torx, a leading platform for drug design and synthesis, will enable a more efficient drug discovery data workflow."

Source: Torx Software